S3845 Genetic testing for alpha-thalassemia

Billable / valid for submission HCPCS Release 2026Q3

Short description: Gene test alpha-thalassemia

Version history

Related codes in S38

• S3800 Genetic testing for amyotrophic lateral sclerosis (als)
• S3840 Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
• S3841 Genetic testing for retinoblastoma
• S3842 Genetic testing for von hippel-lindau disease
• S3844 Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
• S3846 Genetic testing for hemoglobin e beta-thalassemia
• S3849 Genetic testing for niemann-pick disease
• S3850 Genetic testing for sickle cell anemia
• S3852 Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
• S3853 Genetic testing for myotonic muscular dystrophy
• S3854 Gene expression profiling panel for use in the management of breast cancer treatment
• S3861 Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome
• S3865 Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
• S3866 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
• S3870 Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability

All S38 codes →